Director Heart Failure Program, Cedars-Sinai Heart Institute
Cardiology
Dr. Michele A. Hamilton, MD
|
|
Give Review
Michele A. Hamilton works in the field of Cardiology. She researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. She over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACC)". Michele Hamilton is a published doctor and has 92 publications published. The lastest was: 'A controlled trial of exercise rehabilitation after heart transplantation.'
Publications
- Regional hippocampal damage in heart failure.
- Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome.
- The Policy of Placing Older Donors into Older Recipients: Is it Worth the Risk?
- Hormone therapy in women after heart transplantation.
- Pro-HEART - A Randomized Clinical Trial to Test the Effectiveness of a High Protein Diet Targeting Obese Individuals with Heart Failure: Rationale, Design and Baseline...
- Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy.
- Temporal Trends in Treatment and Outcomes for Advanced Heart Failure with Reduced Ejection Fraction from 1993-2010: Findings from a University Referral Center.
- Impaired cerebellar and limbic responses to the valsalva maneuver in heart failure.
- Contraception in patients with heart failure.
- Heart transplant recipients supported with extracorporeal membrane oxygenation: Outcomes from a single-center experience.
- Brain axonal and myelin evaluation in heart failure.
- Global and regional putamen volume loss in patients with heart failure.
- Role of inotropic agents in the treatment of heart failure.
- Is exercise adherence associated with clinical outcomes in patients with advanced heart failure?
- Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart fai...
- Mammillary bodies and fornix fibers are injured in heart failure.
- Long-term outcomes of heart transplantation in older recipients.
- Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure.
- Effects of a home-based exercise program on clinical outcomes in heart failure.
- Aberrant central nervous system responses to the Valsalva maneuver in heart failure.
- Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure.
- B-type natriuretic peptide levels in obese patients with advanced heart failure.
- Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
- Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure.
- Validity of pedometers for measuring exercise adherence in heart failure patients.
- Two-year follow-up of quality of life in patients referred for heart transplant.
- Muscle mechanoreceptor sensitivity in heart failure.
- Regional brain gray matter loss in heart failure.
- Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients.
- Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.
- Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.
- Failing the failing heart: a review of palliative care in heart failure.
- The natural history of biopsy-negative rejection after heart transplantation.
- Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.
- Impact of obesity on quality of life and depression in patients with heart failure.
- Use of two recipient lists for adults requiring heart transplantation.
- Emotional well-being in spouses of patients with advanced heart failure.
- Compliance behaviors of elderly patients with advanced heart failure.
- Exaggerated renal vasoconstriction during exercise in heart failure patients.
- Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.
- Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
- Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure: implications for 'triggering' adverse cardiac events.
- Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.
- Improving survival for patients with atrial fibrillation and advanced heart failure.
- Improving survival for patients with advanced heart failure: a study of 737 consecutive patients.
- The relationship between obesity and mortality in patients with heart failure.
- Educational needs of patients with advanced heart failure and their caregivers.
- Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
- Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
- Is coping style linked to emotional states in heart failure patients?
- Impact of left ventricular cavity size on survival in advanced heart failure.
- The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival.
- Altered thyroid hormone metabolism in advanced heart failure.
- Independent control of skin and muscle sympathetic nerve activity in patients with heart failure.
- Exaggerated muscle mechanoreflex control of reflex renal vasoconstriction in heart failure.
- Emotional well-being of heart failure patients and their caregivers.
- Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure.
- Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens.
- Amiodarone therapy does not compromise subsequent heart transplantation.
- Dynamics of muscle sympathetic nerve activity in advanced heart failure patients.
- Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients ...
- Target heart failure populations for newer therapies.
- Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation.
- Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?
- Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
- Depression in patients with heart failure.
- Improvement in exercise capacity of candidates awaiting heart transplantation.
- Modeling distribution of donor hearts to maximize early candidate survival.
- The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection.
- Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic ...
- Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study.
- Mechanical assist strategy using the BVS 5000i for patients with heart failure.
- Effect of tricuspid regurgitation on the reliability of the thermodilution cardiac output technique in congestive heart failure.
- Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure.
- A controlled trial of exercise rehabilitation after heart transplantation.
- The University of California at Los Angeles heart transplantation experience.
- Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy.
- Lung transplantation and coronary artery disease.
- Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure.
- The University of California at Los Angeles experience in heart transplantation.
- Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure.
- Thyroid hormone abnormalities in heart failure: possibilities for therapy.
- Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.
- Cardiac transplantation at UCLA.
- Cardiac transplantation: the UCLA experience 1984 to 1990.
- Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs.
- Inhaled nitric oxide for pulmonary hypertension after heart transplantation.
- The life stages of weight: setting achievable goals appropriate to each woman.
- Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure.
- Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis.
- The Postoperative Morbidity Survey was validated and used to describe morbidity after major surgery.
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACC)
Education
-
UCLA Medical Center -
Harvard Medical School
Hospital
-
Cedars-Sinai Medical Center -
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Amita R. Dharawat, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahram F. Ravan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jaime D. Moriguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bijan Pourat, MD |
|
|
Dr. Mazen M. Sawaf, MD |